How Morgan Stanley Courted Dodgy Customers to Build a Wealth-Management Empire
Internal company documents describe the bank’s weak anti-money-laundering controls and failure to complete due-diligence ...
Morgan Stanley to Sell NYC Park Avenue Office Condo to SL Green
SL Green Realty Corp. is in contract to purchase the office portion of Manhattan’s 500 Park Ave., the former headquarters of ...
Morgan Stanley's Chris Toomey: What's interesting is what will happen in the 'tails'
Chris Toomey, Morgan Stanley Private Wealth Management managing director, and Cameron Dawson, NewEdge Wealth CIO, join CNBC's ...
Robinhood Gets Morgan Stanley Upgrade, Big Price Target Raise on Trump Win
Key Takeaways Morgan Stanley boosted Robinhood Markets' rating and more than doubled its price target Monday, calling the ...
Kindercare Learning upgraded at Morgan Stanley on attractive valuation, shares climb
Morgan Stanley upgrades KinderCare Learning (KLC) to 'overweight', citing attractive valuation and growth opportunities.
Arabian Business7 小时
Morgan Stanley to set up Mideast regional HQ in Saudi Arabia
The regulatory nod will make it the latest Western bank to expand its operations in the country. “Establishing a regional HQ ...
5 Top Morgan Stanley Mutual Funds To Invest In
Looking for the best Morgan Stanley mutual funds to add to your portfolio? See this list of the top funds to buy now.
How Morgan Stanley Stepped Up its Courtship of Near-IPO Employees as Wealthy Clients
The investment bank signed an agreement with Carta, a shareholder management company for startups, which estimates about ...
Morgan Stanley opens new Southeast Asia headquarters in Singapore
Morgan Stanley said it opened its new Southeast Asia headquarters in Singapore's swanky downtown business district this week.
Lianhe Zaobao8 天
摩根士丹利上调新交所评级 推动其股价大涨逾5%
另外，新交所在过去四个月中相较于主要指数和全球交易所的优异表现，几乎完全是由于截至6月的2024财年业绩上调所致。摩根士丹利认为，新交所股价在长期内还有7％的上涨空间，更高的营收也会使市盈率达到23倍到25倍。
Morgan Stanley上调Doximity股票评级但警告估值过高
周四，Morgan Stanley调整了对Doximity Inc (NYSE:DOCS)的立场，将该股票从减持上调至中性。伴随这一升级的是目标价的大幅提高，现在设定为$53.00，从之前的$33.00大幅上涨。这一修订反映了对公司估值和增长前景的重新评估。 Morgan Stanley的分析师指出，按基本面衡量，Doximity的估值似乎过高，引用了基于2025日历年估计的16倍企业价值与销售额 ...
Morgan Stanley看好Regenxbio股票，强调基因疗法前景
周五，Morgan Stanley恢复了对Regenxbio Inc. (NASDAQ:RGNX)股票的覆盖，给予超配评级，目标价为22.00美元。 该公司的分析认识到基因疗法在治疗VEGF介导疾病方面的潜力，这些疾病目前存在较高的未满足医疗需求。然而，分析师也对商业可行性表示谨慎，因为视网膜下给药方法存在挑战。 分析师指出，虽然Regenxbio的RGX-314脉络膜上腔给药的数据仍处于初步阶段 ...